CurveBeam AI Limited (ASX:CVB – Get Free Report) insider Robert Lilley bought 250,000 shares of the company’s stock in a transaction on Friday, December 6th. The stock was bought at an average price of A$0.12 ($0.08) per share, with a total value of A$29,750.00 ($18,949.04).
CurveBeam AI Stock Performance
About CurveBeam AI
CurveBeam AI Limited engages in the development and manufacture of point-of care specialized weight bearing medical imaging equipment in Europe and North America. The company builds artificial intelligence tools to aid in bone separation and segmentation, empowering orthopedic surgeons to make 3D-based deformity measurements to inform clinical decisions.
Read More
- Five stocks we like better than CurveBeam AI
- How to Calculate Stock Profit
- The Great CPU Race: AMD and Intel Battle for Dominance
- Basic Materials Stocks Investing
- GameStop Turns a Profit: So What? It’s Still Not Worth Investing
- Trading Halts Explained
- C3.ai Stock Surges on Strong Sales Despite Profit Concerns
Receive News & Ratings for CurveBeam AI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CurveBeam AI and related companies with MarketBeat.com's FREE daily email newsletter.
